This white paper highlights the challenges of emerging and re-emerging infectious diseases such as TB, MSSA/MRSA, and Ebola.
Learn more about different genomic assays that can be used during clinical development and which ones are right for your study.
A critical component in the fight against cancer and optimizing treatment outcomes for patients.
Discover how a comprehensive personalized genomics strategy can help you identify the patients who would most likely benefit from a treatment and suffer the least side effects, ensuring the right drug is used in the right patient at the right time.
Discover the role of the central laboratory in Zika vaccine development and how you can proactively avoid challenges along the development continuum.
How advances in genetic engineering have brought new hope to conquering malaria.
Learn what bioinformatics offers to precision medicine and immuno-oncology.
Learn how genomics-based biomarker approaches can empower the success of your immuno-oncology clinical development programs by implementing a tailored biomarker strategy.
Real world experiences, pitfalls and best practices that can improve the efficiency of clinical development when centralizing and managing third party vendors.
The development of immuno-oncology (I/O) medicines offer a new era of treatment options for physicians and patients. However, the level of sophistication required for biomarker selection, trial design, technology implementation, testing, and commercialization planning is unprecedented. Learn more about how clinical trial laboratories are utilizing multiple technologies and solutions to support immuno-oncology clinical development.
|
|
|
|
|
|
|
|
|